Article

Early prediction of preeclampsia in pregnancy with circulating cell-free RNA

2021-03-15

Abstract excerpt

Liquid biopsies that measure circulating cell-free RNA (cfRNA) offer an unprecedented opportunity to noninvasively study the development of pregnancy-related complications and to bridge gaps in clinical care. Here, we used 404 blood samples from 199 pregnant mothers to identify and validate cfRNA transcriptomic changes that are associated with preeclampsia (PE), a multi-organ syndrome which is the second largest c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cb782140-c447-523f-8d0e-177529642c0e
DOI: 10.1101/2021.03.11.21253393

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Early prediction of preeclampsia in pregnancy with circulating cell-free RNADOI 10.1101/2021.03.11.21253393Read

Early prediction of preeclampsia in pregnancy with cell-free RNASemantic proximity Read

RNA profiles reveal signatures of future health and disease in pregnancySemantic proximity Read

Molecular subtyping of hypertensive disorders of pregnancySemantic proximity Read

Placenta at single-cell resolution in early and late preeclampsia: insights and clinical implicationsSemantic proximity Read

Improved Prediction Accuracy for Late-Onset Preeclampsia Using cfRNA Profiles: A Comparative Study of Marker Selection StrategiesSemantic proximity Read

Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamicsSemantic proximity Read

Investigating Pregnancy and Its Complications Using Circulating Cell-Free RNA in Women's Blood During GestationSemantic proximity Read

Characterizing immune variation and diagnostic indicators of preeclampsia by single-cell RNA sequencing and machine learningSemantic proximity Read

Blood biomarkers representing maternal-fetal interface tissues used to predict early-and late-onset preeclampsia but not COVID-19 infectionSemantic proximity Read

Systemic transcriptome comparison between early‐ And late‐onset pre‐eclampsia shows distinct pathology and novel biomarkersSemantic proximity Read

Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studiesSemantic proximity Read

Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.Semantic proximity Read